News | News By Subject | News by Disease News By Date | Search News

HIV/AIDS News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
High School Students "Punched" Martin Shkreli in the Face by Recreating $750 HIV Pill for a Mere $2     12/2/2016
The Drugmaker That Could Knock Gilead (GILD) Off Its HIV Throne     9/20/2016
GlaxoSmithKline (GSK) Execs Set High Hopes for Game-Changing HIV Research Strategy     8/29/2016
Gilead (GILD)'s Odefsey Successful in Two Phase IIIb Studies     7/22/2016
Theratechnologies (TH.TO) Says 82.5% of Patients Achieved Primary Endpoint in Phase III Ibalizumab Trial     5/24/2016
FDA Approves Gilead (GILD)'s Next-Generation HIV Drug Descovy     4/5/2016
FDA Green Lights Gilead (GILD)’s Odefsey to Treat HIV-1 Infection in Certain Patients     3/2/2016
GlaxoSmithKline (GSK) Does Late Holiday Shopping, Buys Two HIV Asset Programs from Bristol-Myers Squibb (BMY) For Up to $2 Billion     12/18/2015
ViiV Healthcare Hitting Hard But Gilead (GILD) Management is Well-Prepared     11/4/2015
Imprimis (immy) Offers $1 Alternative to Turing Pharma's $750 AIDS Drug     10/23/2015
Gilead (GILD)'s New HIV Drug Genvoya Shows Lower Side-Effects Over Longer Term in Two Late-Stage Studies     10/22/2015
Turing Pharma Not Justified in Increasing Daraprim Price by 5,000 Percent, BioSpace Readers Say     9/25/2015
Turing Pharma Becomes Political Football, Donald Trump Weighs In     9/25/2015
Outcry Forces Turing Pharma to Reduce Price Increase of Toxoplasmosis Drug     9/24/2015
GlaxoSmithKline (GSK)'s ViiV Healthcare Successful But Heat From Gilead (GILD) May Be Its Downfall     7/9/2015

News from Around the Web
New Approach Makes Cells Resistant To HIV, The Scripps Research Institute Reveals     4/11/2017
The 3 Best HIV Drug Stocks To Buy In 2017     4/10/2017
Gazing Into The Crystal Ball For Advaxis (ADXS): What To Expect At ASCO 2017     4/7/2017
MRI Scans Can Help Spot HIV In The Brain, University College London Reveals     3/13/2017
Gilead (GILD): Buy The HIV Franchise And Get The Rest For Almost Free     2/28/2017
Cheap Ultrasensitive HIV Sensor To Help Screen Virus In Poorer Places, Instituto de Microelectrónica de Madrid Reveals     2/23/2017
Antiretroviral Therapy May Lead To Syphilis In HIV-Positive Men, Johns Hopkins University School of Medicine Study     1/20/2017
Massive Drop In London HIV Rates May Be Due To Internet Drugs, London School of Hygiene and Tropical Medicine Study     1/11/2017
The GlaxoSmithKline (GSK)-Gilead (GILD) HIV Battle Could Be Epic     12/29/2016
Needle Exchanges, Once Met With Fierce Resistance, Are Working     12/6/2016
Why Can't We Bring Down The Number Of New HIV Cases?     12/1/2016
Injections, Implants Tested As New Weapons To Prevent HIV     11/30/2016
Experimental Vaginal Ring Fights HIV, But Will Women Wear It?     11/16/2016
Imperial College London Scientists Develop New Type Of HIV Test On A USB Stick     11/10/2016
Magic Johnson's HIV Story Offers Hope For Cancer Patients     11/8/2016

Press Releases
Inovio Pharma (INO) HIV Vaccine Elicits Nearly 100% Immune Response Rates In A Clinical Study     5/24/2017
CLJI Worldwide Trial Enrolls First Patient In Clinical Study Evaluating The Performance Of VIBLOK As A Barrier For Herpes Simplex Virus Transmission In Men And Women     5/24/2017
Napo Pharmaceuticals, Inc.’ New Mytesi Video Calls Attention To The Continuing Widespread Problem Of Diarrhea In People Living With HIV/AIDS     5/24/2017
Immune Therapeutics Announces NAFDAC Approval For Marketing And Distribution Of Lodonal     5/22/2017
Gladstone Institute Release: Study Reveals A New Method To Address A Major Barrier To Eradicating HIV     5/12/2017
Gilead (GILD) Release: Multiple Provinces And Territories Demonstrate Leadership In The Treatment Of HIV/AIDS By Providing Access To GENVOYA     5/8/2017
Theratechnologies (TH.TO) Partner Submits Biologics License Application For HIV Monoclonal Antibody And Long-Acting Investigational Antiretroviral Ibalizumab     5/4/2017
Abivax (ABVX.PA) Stock More Than Doubles On Mid-Stage HIV Data     5/2/2017
ExeGi Pharma Release: Multi-Strain Probiotic May Play A Role In The Recovery Of Critical Gastrointestinal Functions In HIV-1-Positive Patients     5/2/2017
REPLICor Inc. Discloses Achievement Of 1 Year Functional Control Of HBV And HDV With Naps And New Mechanistic Insights In NAP Pharmacology     4/20/2017
Kowa Pharmaceuticals America Announces INTREPID Trial Results In The Lancet HIV Showing Superior LDL Cholesterol Reduction With LIVALO (Pitavastatin) Compared With Pravastatin In Adults With HIV And Dyslipidemia     4/19/2017
Potential For CytoDyn (CYDY)’s PRO 140 For Treating HIV Patients Deemed Too Broad For Orphan Drug Designation By The FDA     4/17/2017
RTT MolecularDX Launches HIV-1, HBV And HCV Drug Resistance And GeneTHINK Fully Integrated System     4/12/2017
New Approach Makes Cells Resistant To HIV, The Scripps Research Institute Reveals     4/11/2017
ABIVAX Initiates Clinical Trial (ABX464-005) To Evaluate The Effect Of ABX464 On HIV-Reservoirs In HIV Patients     4/5/2017

//-->